Amgen Inc.’s anti-inflammatory medication Enbrel causes “life-threatening” side effects in children with psoriasis, U.S. regulators said in a report that cast doubt about whether the drug can win ...
Biologic drugs that treat various autoimmune disorders have seen substantial increases in prescriptions over the last 20 years. The drugs are effective in treating rheumatoid arthritis, psoriasis and ...
THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel ® ...